Cargando…
Targeted Chronic Myeloid Leukemia Therapy: Seeking a Cure
BACKGROUND: Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCr-ABL fusion protein that arises from the translocation of chromosomes 9 and 22. The disease begins with an indolent chronic phase (CP) that can last for 3 to 5 years. If untreated, it progresses into acce...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437886/ https://www.ncbi.nlm.nih.gov/pubmed/17970609 http://dx.doi.org/10.18553/jmcp.2007.13.s8-a.8 |